BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 9720584)

  • 1. Cyclin D1 protein overexpression is related to tumor differentiation, but not to tumor progression or proliferative activity, in transitional cell carcinoma of the bladder.
    Suwa Y; Takano Y; Iki M; Takeda M; Asakura T; Noguchi S; Masuda M
    J Urol; 1998 Sep; 160(3 Pt 1):897-900. PubMed ID: 9720584
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclin E overexpression in transitional cell carcinoma of the bladder.
    Makiyama K; Masuda M; Takano Y; Iki M; Asakura T; Suwa Y; Noguchi S; Hosaka M
    Cancer Lett; 2000 Apr; 151(2):193-8. PubMed ID: 10738114
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclin D1 expression in transitional cell carcinoma of the bladder: correlation with p53, waf1, pRb and Ki67.
    Tut VM; Braithwaite KL; Angus B; Neal DE; Lunec J; Mellon JK
    Br J Cancer; 2001 Jan; 84(2):270-5. PubMed ID: 11161387
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Apoptosis, proliferation and p53, cyclin D1, and retinoblastoma gene expression in relation to radiation response in transitional cell carcinoma of the bladder.
    Moonen L; Ong F; Gallee M; Verheij M; Horenblas S; Hart AA; Bartelink H
    Int J Radiat Oncol Biol Phys; 2001 Apr; 49(5):1305-10. PubMed ID: 11286838
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inverse correlation between high level expression of cyclin E and proliferation index in transitional cell carcinoma of the bladder.
    Khan AA; Abel PD; Chaudhary KS; Gulzar Z; Stamp GW; Lalani EN
    Mol Pathol; 2003 Dec; 56(6):353-61. PubMed ID: 14645699
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of p16 and cyclin D1 in bladder cancer and correlation in cancer progression.
    Yang CC; Chu KC; Chen HY; Chen WC
    Urol Int; 2002; 69(3):190-4. PubMed ID: 12372886
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of cyclin D1 and E1 expression with disease progression and biomarkers in patients with nonmuscle-invasive urothelial cell carcinoma of the bladder.
    Shariat SF; Ashfaq R; Sagalowsky AI; Lotan Y
    Urol Oncol; 2007; 25(6):468-75. PubMed ID: 18047954
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of cyclin D1, but not cyclins E and A, is related to progression in bilharzial bladder cancer.
    Osman I; Scher H; Zhang ZF; Soos TJ; Hamza R; Eissa S; Khaled H; Koff A; Cordon-Cardo C
    Clin Cancer Res; 1997 Dec; 3(12 Pt 1):2247-51. PubMed ID: 9815621
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic factors in survival of patients with stage Ta and T1 bladder urothelial tumors: the role of G1-S modulators (p53, p21Waf1, p27Kip1, cyclin D1, and cyclin D3), proliferation index, and clinicopathologic parameters.
    Lopez-Beltran A; Luque RJ; Alvarez-Kindelan J; Quintero A; Merlo F; Requena MJ; Montironi R
    Am J Clin Pathol; 2004 Sep; 122(3):444-52. PubMed ID: 15362377
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of pS2 protein and its relation with the Ki-67 proliferative indices and tumor recurrence in superficial bladder carcinomas.
    Sagol O; Yörükoglu K; Tuna B; Ozer E; Sis B; Güray M; Mungan U; Kirkali Z
    Eur Urol; 2001 Aug; 40(2):163-8. PubMed ID: 11528193
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Significance of cyclin D1 overexpression in transitional cell carcinomas of the urinary bladder and its correlation with histopathologic features.
    Lee CC; Yamamoto S; Morimura K; Wanibuchi H; Nishisaka N; Ikemoto S; Nakatani T; Wada S; Kishimoto T; Fukushima S
    Cancer; 1997 Feb; 79(4):780-9. PubMed ID: 9024716
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclin D1 overexpression in rat two-stage bladder carcinogenesis and its relationship with oncogenes, tumor suppressor genes, and cell proliferation.
    Lee CC; Yamamoto S; Wanibuchi H; Wada S; Sugimura K; Kishimoto T; Fukushima S
    Cancer Res; 1997 Nov; 57(21):4765-76. PubMed ID: 9354438
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of cell cycle proteins in T1a and T1b urothelial bladder carcinoma and their value in predicting tumor progression.
    Mhawech P; Greloz V; Oppikofer C; Szalay-Quinodoz I; Herrmann F
    Cancer; 2004 Jun; 100(11):2367-75. PubMed ID: 15160340
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyclin D1 expression in papillary superficial bladder cancer: its association with other cell cycle-associated proteins, cell proliferation and clinical outcome.
    Sgambato A; Migaldi M; Faraglia B; De Aloysio G; Ferrari P; Ardito R; De Gaetani C; Capelli G; Cittadini A; Trentini GP
    Int J Cancer; 2002 Feb; 97(5):671-8. PubMed ID: 11807796
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence of apoptosis, cell proliferation and bcl-2 expression in transitional cell carcinoma of the bladder: association with tumor progression.
    King ED; Matteson J; Jacobs SC; Kyprianou N
    J Urol; 1996 Jan; 155(1):316-20. PubMed ID: 7490878
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beta-catenin mutations correlate with over expression of C-myc and cyclin D1 Genes in bladder cancer.
    Shiina H; Igawa M; Shigeno K; Terashima M; Deguchi M; Yamanaka M; Ribeiro-Filho L; Kane CJ; Dahiya R
    J Urol; 2002 Nov; 168(5):2220-6. PubMed ID: 12394763
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of p21WAF1/CIP1 and cyclin D1 expression in the progression of superficial bladder cancer. Finbladder Group.
    Liukkonen T; Lipponen P; Raitanen M; Kaasinen E; Ala-Opas M; Rajala P; Kosma VM
    Urol Res; 2000 Oct; 28(5):285-92. PubMed ID: 11127704
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunohistochemical demonstration of cyclin D1 in bladder cancers as an inverse indicator of invasiveness but not an independent prognostic factor.
    Takagi Y; Takashi M; Koshikawa T; Sakata T; Ohshima S
    Int J Urol; 2000 Oct; 7(10):366-72. PubMed ID: 11144504
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpression of cyclin D1 correlates with early recurrence in superficial bladder cancers.
    Shin KY; Kong G; Kim WS; Lee TY; Woo YN; Lee JD
    Br J Cancer; 1997; 75(12):1788-92. PubMed ID: 9192983
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alterations affecting the p53 control pathway in bilharzial-related bladder cancer.
    Osman I; Scher HI; Zhang ZF; Pellicer I; Hamza R; Eissa S; Khaled H; Cordon-Cardo C
    Clin Cancer Res; 1997 Apr; 3(4):531-6. PubMed ID: 9815716
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.